The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Obsessive–Compulsive Disorder
Abstract
A 33-year-old woman presents with a seven-year history of hand washing for two to six hours a day, as well as urges to check doors and stoves extensively before leaving her home. Her life is restricted, and her family members are upset about her behavior. How should she be evaluated and treated?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
A family study of obsessive–compulsive disorder
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.1.76 · Cited by 1,022
A Family Study of Obsessive-compulsive Disorder
Nestadt, G., Samuels, J., Riddle, M., Bienvenu, O. J., Liang, K.-Y., LaBuda, M., Walkup, J., Grados, M., & Hoehn-Saric, R. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.4.358 · Cited by 657
Abramowitz, J. S. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.65.1.44 · Cited by 490
A Review of the Efficacy of Selective Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder
Pigott, T. A., & Seay, S. M. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0206 · Cited by 454
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.6.867 · Cited by 315
Marks, I. M., Hodgson, R., & Rachman, S. J. (1975) · British Journal of Psychiatry · doi:10.1192/bjp.127.4.349 · Cited by 315
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.12.1521 · Cited by 301
Gabriëls, L., Cosyns, P., Nuttin, B., Demeulemeester, H., & Gybels, J. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2003.00066.x · Cited by 298
van Balkom, A. (1994) · Clinical Psychology Review · doi:10.1016/0272-7358(94)90033-7 · Cited by 285
Research works printed but not linked: 11
- 1997, J Clin Psychiatry, 58, 2
- Carey G, Gottesman I. Twin and family studies of anxiety, phobic, and obsessive disorders. In: Klein DF, Rabkin JG, eds. Anxiety: new research and changing concepts. New York: Raven Press, 2000:117-36.
- Nicolini H, 1991, Ursus Medicus, 1, 25
- Nestadt G, 2000, Am J Med Genet, 67, 1611
- Jenike MA, Baer L, Minichiello WE, eds. Obsessive-compulsive disorders: practical management. 3rd ed. St. Louis: Mosby, 1998.
- Jenike MA, 1993, Psychopharmacol Bull, 29, 487
- Goodman WK, 1992, J Clin Psychiatry, 53, 29
- 10.3109/10673229309017053 · doi:10.3109/10673229309017053
- Pato MT, 1990, Psychopharmacol Bull, 26, 211
- Ravizza L, 1996, Psychopharmacol Bull, 32, 167
- 10.1176/appi.ajp.157.5.839-a · doi:10.1176/appi.ajp.157.5.839-a
Cited by
Hu, X.-Z., Lipsky, R. H., Zhu, G., Akhtar, L. A., Taubman, J., Greenberg, B. D., Xu, K., Arnold, P. D., Richter, M. A., Kennedy, J. L., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/503850 · Cited by 1,123
Pittenger, C., Bloch, M. H., & Williams, K. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.09.006 · Cited by 426
“Affected individuals can spend hours a day in this cycle of obsession and compulsion, producing substantial morbidity (Koran et al., 1996; Jenike, 2004).”
BackgroundInfluentialRiluzole augmentation in treatment-resistant obsessive-compulsive disorder: An open-label trial
Coric, V., Taskiran, S., Pittenger, C., Wasylink, S., Mathalon, D. H., Valentine, G., Saksa, J., Wu, Y.-T., Gueorguieva, R., Sanacora, G., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.043 · Cited by 314
Contemporary assessment and pharmacotherapy of Tourette syndrome
Scahill, L., Erenberg, G., Berlin, C. M., Budman, C., Coffey, B. J., Jankovic, J., Kiessling, L., King, R. A., Kurlan, R., Lang, A., et al. (2006) · NeuroRX · doi:10.1016/j.nurx.2006.01.009 · Cited by 300
Anticevic, A., Hu, S., Zhang, S., Savic, A., Billingslea, E., Wasylink, S., Repovs, G., Cole, M. W., Bednarski, S., Krystal, J. H., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.021 · Cited by 268
“Obsessive-compulsive disorder (OCD) is characterized by intrusive, anxiety-producing thoughts and repetitive, compulsive behaviors, which cause enormous distress(1,2).”
Luyten, L., Hendrickx, S., Raymaekers, S., Gabriëls, L., & Nuttin, B. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.124 · Cited by 264
Berlim, M. T., Neufeld, N. H., & Van den Eynde, F. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.03.022 · Cited by 219
Ting, J. T., & Feng, G. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.04.010 · Cited by 143
“While there are several treatment options currently available [3,4], the stark reality is that there remains a significant percentage of OCD sufferers that are either non-responsive or only partially responsive to the available treatment paradigms.”
BackgroundDougherty, D. D., Brennan, B. P., Stewart, S. E., Wilhelm, S., Widge, A. S., & Rauch, S. L. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0930 · Cited by 131
Role of dopamine in the pathophysiology and treatment of obsessive–compulsive disorder
Koo, M.-S., Kim, E.-J., Roh, D., & Kim, C.-H. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.148 · Cited by 125
Need for speed: Evaluating slopes of OCD recovery in behavior therapy enhanced with d-cycloserine
Chasson, G. S., Buhlmann, U., Tolin, D. F., Rao, S. R., Reese, H. E., Rowley, T., Welsh, K. S., & Wilhelm, S. (2010) · Behaviour Research and Therapy · doi:10.1016/j.brat.2010.03.007 · Cited by 106
“Indeed, of those patients who initially seek behavior therapy for OCD, 25% of patients decline participation in ERP and a similar percentage of patients drop out once initiated (Jenike, 2004; Schruers, Koning, Luermans, Haack, & Griez, 2005).”
Hanstede, M., Gidron, Y., & Nyklíček, I. (2008) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0b013e31818786b8 · Cited by 101
Disorders of memory and plasticity in psychiatric disease
Pittenger, C. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.4/cpittenger · Cited by 92
“OCD is also characterized by maladaptive inflexible patterns of behavior.(84) Increased activation of the basal ganglia circuitry is well established in this condition, as is pathology of the prefrontal cortex.”
BackgroundHamani (2014) · doi:10.1227/neu.0000000000000499 · Cited by 98
Obsessive‐compulsive disorder in the DSM‐5.
Abramowitz, J. S., & Jacoby, R. J. (2014) · Clinical Psychology: Science and Practice · doi:10.1111/cpsp.12076 · Cited by 86
Lusicic, A., Schruers, K. R., Pallanti, S., & Castle, D. J. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s121140 · Cited by 81
Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults
Greenberg, W. M., Benedict, M. M., Doerfer, J., Perrin, M., Panek, L., Cleveland, W. L., & Javitt, D. C. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.10.007 · Cited by 80
STEEVES, T., & FOX, S. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00924-2 · Cited by 79
Resting state functional connectivity predicts neurofeedback response
Scheinost, D., Stoica, T., Wasylink, S., Gruner, P., Saksa, J., Pittenger, C., & Hampson, M. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00338 · Cited by 70
“Obsessive-compulsive disorder (OCD) is characterized by intrusive obsessions, which are often associated with anxiety, and with repetitive compulsions that seek to control that anxiety (Jenike, 2004).”
BackgroundInfluentialObsessive-compulsive disorder: update on assessment and treatment.
BJÖRGVINSSON, T., HART, J., & HEFFELFINGER, S. (2007) · Journal of Psychiatric Practice® · doi:10.1097/01.pra.0000300122.76322.ad · Cited by 65
Sarris, J., Camfield, D., & Berk, M. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.04.051 · Cited by 59
Functional disruption of cerebello-thalamo-cortical networks in obsessive-compulsive disorder
Sha, Z., Edmiston, E. K., Versace, A., Fournier, J. C., Graur, S., Greenberg, T., Lima Santos, J. P., Chase, H. W., Stiffler, R. S., Bonar, L., et al. (2020) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2019.12.002 · Cited by 48
“Obsessive-compulsive disorder(OCD) affects 1–3% of the population(1,2) and is characterized by intrusive thoughts(obsessions) and repetitive behaviors(compulsions)(3,4).”
Midbrain dopamine neurons arbiter OCD-like behavior
Xue, J., Qian, D., Zhang, B., Yang, J., Li, W., Bao, Y., Qiu, S., Fu, Y., Wang, S., Yuan, T.-F., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2207545119 · Cited by 40
“In clinical practice, around half of OCD patients failed to exhibit a response to serotonin-reuptake inhibitors treatment (53); however, they were responding to DA antagonists (54, 55).”
BackgroundRaines, A. M., Short, N. A., Sutton, C. A., Oglesby, M. E., Allan, N. P., & Schmidt, N. B. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.05.081 · Cited by 29
Grant, J. E., Hook, R., Valle, S., Chesivoir, E., & Chamberlain, S. R. (2021) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000368 · Cited by 24
On astrocyte-neuron interactions: broad insights from the striatum
Khakh, B. S. (2025) · Neuron · doi:10.1016/j.neuron.2025.08.009 · Cited by 23
A closer look to neural pathways and psychopharmacology of obsessive compulsive disorder
Gargano, S. P., Santos, M. G., Taylor, S. M., & Pastis, I. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1282246 · Cited by 18
“While approximately half of OCD patients fail to have a clinically significant response to SSRI treatment in practice (Jenike, 2004), these treatment-resistant patients have displayed a response to dopamine antagonists (Maina et al., 2008; Goodwin et al., 2009).”
Metadata
- Authors
- Jenike, M. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-01-15
- Volume
- 350
- Issue
- 3
- Pages
- 259-265
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2006561512
- Cited by
- 259
- References
- 42
- FWCI
- 16.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.